<unk>  is a kinase inhibitor indicated for the treatment of * adults with non-small cell lung cancer (NSCLC) which has spread to other parts of the body (metastatic). * adults and children twelve years of age and older with advanced or metastatic medullary thyroid cancer (MTC). * adults and children twelve years of age and older with advanced or metastatic thyroid cancer who have received radioactive iodine that did not work or is no longer working.
Selpercatinib
Tucatinib
Fostamatinib
Brigatinib
Neratinib
Capmatinib
Infigratinib
Lapatinib